Orchid Pharma Limited has submitted a Confirmation Certificate for the fourth quarter of the Financial Year 2025-26, which ended on March 31, 2026. This certificate, issued by M/s. Abhipra Capital Limited, the company's Registrar and Share Transfer Agent, confirms compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended. The company has informed the National Stock Exchange of India Limited and the BSE Limited about this submission. The certificate attests to the required compliances under the aforementioned SEBI regulations for the specified period. The company has requested that this intimation be taken on record.
